Kathy Baker: Founding My Faulty Gene & Surviving Hereditary Cancer
Release Date: 09/10/2026
Kathy Baker: Founding My Faulty Gene & Surviving Hereditary Cancer
Walking the Genetic Line
EPISODE SUMMARY Kathy Baker grew up in a family that, as she puts it, "looked like a poster for a BRCA mutation" — a sister diagnosed with breast cancer at 31, a mother with three primary cancers, a grandfather lost to aggressive prostate cancer, a great-grandmother lost to pancreatic cancer. And still, when genetic testing became available, Kathy said no. Not out of denial exactly, but out of a fierce instinct to protect her own life from being lived under a shadow. She was diagnosed with breast cancer herself in 2000, treated without ever seeing an oncologist first, and then spent nine...
info_outline
Elana Silber: The Chain You Inherit
Walking the Genetic Line
EPISODE SUMMARY Sharsheret is the Hebrew word for chain. Not a ribbon, not a fight, not a cure — a chain. Twenty-five years in, that name turns out to be the most precise available description of the work: over 40,000 people who have shared their experience, peer matches made not by mutation status but by the specific thing you are afraid of, social workers and genetic counselors who answer the phone, pre- and post-surgery kits arriving at the house wrapped and unbilled, and more than a million dollars a year moving quietly toward the non-medical costs that make a diagnosis expensive in ways...
info_outline
Holly Taylor: Hard-Earned Wisdom
Walking the Genetic Line
Episode Summary A visible tumor changed two lives at once. When Holly Taylor’s sister was diagnosed at 45 with simultaneous stage 3 ovarian and breast cancer — tumors large enough to see with the naked eye, discovered only after years of avoiding care without health insurance — genetic testing entered Holly’s life as an extension of her sister’s crisis rather than a decision of her own. An initial variant of unknown significance sat unresolved for two years before being reclassified as a pathogenic BRCA1 mutation, arriving in the middle of a four-and-a-half-year caregiving arc that...
info_outline
Marleah Dean Kruzel: You Make the Best Decision You Can — A Researcher’s Honest Take on BRCA and Uncertainty
Walking the Genetic Line
Guest: Marleah Dean Kruzel, PhD Theme: Uncertainty as a Lifetime Companion, Not a Problem to Solve Episode Summary Marleah Dean Kruzel was 8 years old when her mother found a lump. What followed were years of surgeries, chemotherapy, radiation, and a childhood lived largely in hospitals — experiences that eventually became the foundation of a research career dedicated to understanding what previvors actually go through, and what the systems meant to support them consistently fail to provide. She tested positive for BRCA2 in 2013, after letting the test kit sit in the back of her safe for...
info_outline
Natalie Samson Hart: How Integrative Genetic Counseling Changes What Comes Next
Walking the Genetic Line
Guest: Natalie Samson Hart, MS, CGC, INHC Theme: Genetic Counseling as a Gateway to Whole-Person Care Episode Summary Natalie Samson Hart didn’t come to oncology genetic counseling through a tidy career trajectory. She came through loss, confusion, and proximity to illness — a brother whose neurodivergence led her toward the intersection of science and human connection, a father diagnosed with stage 4 cancer while she was still in graduate school and rotating through cancer wards. That collision of the personal and professional is what eventually pushed her out of traditional...
info_outline
Krista Brown: ATM Mutation, Delayed Diagnosis, and What Self-Advocacy Actually Costs
Walking the Genetic Line
Guest: Krista (Oncology Nurse Navigator) Theme: Self-Advocacy, ATM Mutation, Cancer After Previvorhood EPISODE SUMMARY When Krista's mother was 48, she became the first known cancer diagnosis in their family. She tested negative for BRCA mutations and felt relief — relief that she wouldn't pass anything on to her children. Twelve years later, just before entering hospice, she was offered expanded genetic testing and found out she carried a pathogenic ATM variant. She shared those results with her children. A few months after her death, Krista — 38 years old, a nurse, carrying...
info_outline
Ali Hall: Prophylactic Mastectomy, Queer Identity, and Claiming Your Body on Your Own Terms
Walking the Genetic Line
Guest: Ali Hall Theme: Queer Identity, Bodily Autonomy, and the BRCA Diagnosis Nobody Saw Coming Episode Summary When Ali Hall stole a 23andMe kit from a family white elephant exchange, she wasn't looking for anything life-changing. Five years later, an email arrived while she was picking her kid up from school: her results had been updated. She had a BRCA mutation. What followed wasn't panic — and that itself is the story. Ali's response was shaped by something older than the diagnosis: a lifelong pattern of minimizing her own experience when people around her were...
info_outline
Jennifer Mercer: Lynch Syndrome Awareness and the Weight of a Father's Legacy
Walking the Genetic Line
Episode Summary Jennifer never knew her biological father growing up — and when she finally let him back into her life at 25, what he brought with him was a medical history that would change everything. Phone call after phone call, a new cancer. Eight-plus organ cancers. Over a hundred skin cancers. Years before anyone thought to offer him a genetic test. When Lynch Syndrome MSH2 was finally identified, Jennifer wasn't ready — she was a single mother, financially stretched, emotionally guarded, and carrying decades of unresolved grief toward a man who had never shown up for her. She put...
info_outline
Solo Episode: Living with Hereditary Cancer and Risk in a Loud World
Walking the Genetic Line
Host: Sara Champie, LCSW Theme: Navigating medical vulnerability, global instability, and nervous system overwhelm during hereditary cancer risk and treatment. Episode summary What happens when your body is healing, your life is medically uncertain, and the world around you feels like it’s unraveling? In this solo episode, therapist Sara Champie explores a reality many people navigating hereditary cancer risk quietly experience: the nervous system strain of managing personal medical vulnerability while absorbing the constant noise of global crisis. When surgery, treatment, or high-stakes...
info_outline
Katie McMurray: The Emotional Impact of Grief, Sisterhood, and Preventative Surgery
Walking the Genetic Line
Guest: Katie McMurray Theme: BRCA1, sisterhood, developmental trauma, and choosing preventative surgery in young adulthood Episode summary When Katie was 17, she lost her mother to breast cancer. Years later, genetic testing confirmed what she had long suspected: she carries a BRCA1 mutation. In this episode, Katie and Sara Champie explore what happens when grief resurfaces through genetic testing — how identity shifts, how fear and agency intertwine, and how the loss of a parent shapes medical decision-making. At 25, during the height of COVID, Katie chose preventative mastectomy surgery....
info_outlineEPISODE SUMMARY
Kathy Baker grew up in a family that, as she puts it, "looked like a poster for a BRCA mutation" — a sister diagnosed with breast cancer at 31, a mother with three primary cancers, a grandfather lost to aggressive prostate cancer, a great-grandmother lost to pancreatic cancer. And still, when genetic testing became available, Kathy said no. Not out of denial exactly, but out of a fierce instinct to protect her own life from being lived under a shadow. She was diagnosed with breast cancer herself in 2000, treated without ever seeing an oncologist first, and then spent nine years declining the genetic testing her oncologist gently, patiently kept raising — until a single statistic changed her mind.
What happened next is the kind of story that reframes what "protective" actually means. Kathy tested positive for a BRCA1 mutation alongside her sister, honored a promise to her dying mother, and underwent ten hours of piggybacked surgery with three surgeons working in tandem — only to learn, mid-procedure, that she already had early-stage ovarian cancer no one knew was there. It's a story about the long, human runway between having information and being ready to use it, and about what Kathy built afterward: a nonprofit that funds the testing other people can't yet afford, or aren't ready, or don't know they're allowed to ask for.
WE COVER
- Growing up in a family history so dense with cancer it reads like a genetics textbook — and why that didn't automatically translate to testing
- Kathy's decision, in her twenties and thirties, not to pursue early mammograms or testing: "I didn't want to live in fear of cancer"
- Her 2000 breast cancer diagnosis, the surgery choices she made without a genetic counselor in the room, and what she'd do differently in hindsight
- The nine years her oncologist quietly kept raising genetic testing — and the study that finally moved her to say yes
- Testing BRCA1 positive alongside her sister, and the promise she made her dying mother to pursue risk-reducing surgery
- The ten-hour, three-surgeon surgery that uncovered an early ovarian cancer no one expected to find
- Founding My Faulty Gene in 2020 to fund germline genetic testing for people who fall outside insurance criteria
- Why cascade testing — testing the family members of someone with a known mutation — is Kathy's central focus, and why fewer than 10% of relatives ever follow through
- The emotional and family-system barriers underneath low cascade testing rates: avoidance, fear, and families that don't talk about hard things
- Real-world access barriers: the cost of testing, the lack of paid leave for self-employed patients, and life insurance underwriting for known mutation carriers
HIGHLIGHTS & TAKEAWAYS
- "Not knowing doesn't change whether you have it or not. All it changes is how you can respond — and whether you respond."
- "I've already told you I'm not that compliant patient... I am not somebody who would have presented with the vague symptoms of ovarian cancer. I would not be here."
- "I was spared for a reason. I really believe that."
- "How can I not? I've been given a great gift. How can I not?"
- On persuading reluctant family members: "Everyone knows when they see me that I'm coming to talk to them."
- "If you have the ability to go and buy a $300 purse, spend that money this month on your own testing."
CONTENT NOTE
This episode names breast cancer diagnosis and treatment, an unexpected ovarian cancer discovery, a parent's death from cancer, major risk-reducing surgery (double mastectomy, hysterectomy, bilateral salpingo-oophorectomy), family history of multiple cancers across generations, financial strain during cancer treatment, life insurance discrimination against mutation carriers, and the host's own disclosure of losing her mother to ovarian cancer at age ten.
RESOURCES MENTIONED
- My Faulty Gene — myfaultygene.org — Kathy's nonprofit, funding germline genetic testing for patients who don't meet insurance criteria for coverage
- Family Gene Share — familygeneshare.org — an educational video series of patient stories, created to help families start cascade testing conversations
- FORCE (Facing Our Risk of Cancer Empowered) — referenced as an ally organization in the hereditary cancer space
- OCRA (Ovarian Cancer Research Alliance) — referenced as offering limited free testing under specific guidelines
- J Screen — genetic testing and counseling partner organization
- KIC (Knowledge is Cancer's Kryptonite) — partner organization referenced in the episode
- The Metcalf study — research on ovarian cancer risk in BRCA1/BRCA2 carriers, referenced as the turning point in Kathy's decision to test
Connect
If this episode moved something in you, follow, rate, and share Walking the Genetic Line — it helps this conversation reach the people who need it. Follow Sara Champie, LCSW at @SaraChampieLCSW for more.
Let's walk this line, together.
Additional support
If this episode brought up grief, fear, or decision fatigue around your own genetic risk or family history, you don't have to sit with it alone. Sara Champie, LCSW offers trauma-informed therapy for people navigating hereditary cancer risk, genetic testing decisions, and preventive or reconstructive surgery.
Sara Champie